Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 May 2018 Photo Reg Caldecott
Yet another victory for Kesa
Kesa Molotsane crossing the line at the second Spar women’s challenge in Port Elizabeth on Saturday morning. She also won the first race in March.

Kesa Molotsane, ace distance runner of the University of the Free State (UFS) continued her rich vein of form on Saturday (May 5) by registering yet another win.

Molotsane coasted to victory in the Spar women’s 10km challenge in Port Elizabeth. Her winning time was 33:46 minutes, 15 seconds ahead of rival and reigning South African cross-country champion, Glenrose Xaba.

Molotsane also reigned supreme in the first race towards the end of March in Cape Town in a time of 34:10. There are six races in total and last year Molotsane was crowned the overall champion in which she achieved her personal best of 32:59.

Just a week before, the 26-year-old smashed the national student record in the 10000m by a massive three minutes and five seconds at the University Sport South Africa champs. The record now stands at 34:49.16.

She was one of two Kovsies to walk away with two gold medals (in the 5000m and 10000m).

“I wasn’t in the right frame of mind and I couldn’t run according to my original plan. It was only at about 5km that I really felt I was in the race. I’m a fighter and at 7km I felt I had to go for it,” Molotsane said about Saturday’s race.

8108 runners entered the 10km challenge and the 5km fun run.

According to Molotsane she is struggling to juggle her track running, cross-country and Spar races.

“I’m trying to qualify for the 5000m at the African championships. I still want to do all three disciplines, although I will eventually have to decide on one.”

News Archive

Death may come in adorable little packages
2015-03-23

The main host of the Lassa virus is the Natal Mulimammate mouse.

Photo: Supplied

Postdoctoral researcher, Abdon Atangana, of the Institute for Groundwater Studies at the university recently published an article online about the Lassa Haemorrhagic fever in the Natural Computing Applications Forum. In addition to the terminal transmissible sickness recognised as Ebola haemorrhagic fever, there is another strain called Lassa haemorrhagic fever.

The disease is classified under the arenaviridae virus family. The first outbreaks of the disease were observed in Nigeria, Liberia, Sierra Leone, and the Central African Republic. However, it was first described in 1969 in the town of Lassa, in Borno State, Nigeria.

The main host of the Lassa virus is the Natal Mulimammate mouse, an animal indigenous to most of Sub-Saharan Africa. The contamination in humans characteristically takes place through exposure to animal excrement through the respiratory or gastrointestinal tracts.

Mouthfuls of air containing tiny particle of infective material are understood to be the most noteworthy way of exposure. It is also possible to acquire the infection through broken skin or mucous membranes that are directly exposed to the infective material.

“The aim of my research was to propose a novel mathematical equation used to describe the spread of the illness amongst pregnant women in West Africa. To achieve this, I used my newly-proposed derivative with fractional order called beta-derivative. Since none of the commonly used integral transform could be used to derive the solution of the proposed model, I proposed a new integral transform called Atangana-Transform, and used it, together with some iterative technique, to derive the solution of the model.

“My numerical simulations show that the disease is as deadly amongst pregnant women as Ebola,” Abdon said.

Abdon’s research was submitted to one of Springer’s top-tier journals with an impact factor 1.78. The paper was accepted and published February 2015.

Read more about Abdon’s research.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept